The Gillett Health Q&A | The Gillett Health Podcast #12

About this video

In this wide-ranging Q&A, Gillett answers audience questions on finasteride and creatine, post-finasteride syndrome, sex hormone-binding globulin, statins, and cognition. He argues creatine is generally well studied while noting no drug or supplement is risk-free, and he discusses proposed neurosteroid mechanisms behind persistent finasteride side effects and why baseline hormone assessment matters before starting. On SHBG, he cautions against chasing a number in isolation, linking it instead to metabolic health, diet pattern, and contraceptive choice. The episode closes with lifestyle foundations for cognition — sleep, stress, and metabolic health — and a study he cites suggesting phone proximity alone can impair focus.

Key takeaways

• Assess baseline hormones and personal risk before starting finasteride, Gillett advises
• Treat SHBG as a metabolic context marker, not a target to force up or down
• No supplement is risk-free even when evidence for harm is weak
• Gillett argues sleep, stress, and metabolic health drive most cognitive performance
• Removing a phone from the room is presented as a simple focus intervention

Episode details: published October 3, 2022 · 1.1K views · 46:30 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.

← Previous: Is Semaglutide Right For You? | The Gillett Health Podcast #12 · Next: All Things Hair Loss Pt.1 | The Gillett Health Podcast #22 →

All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)